Skip to search formSkip to main contentSkip to account menu

von Hippel-Lindau peptide vaccine

Known as: VHL Peptides, VHL peptide, VHL peptide vaccine 
A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide… 
National Institutes of Health

Related topics

Related topics

2 relations
Antigen Sensitizationincomplete Freund's adjuvant/interleukin-2/von Hippel-Lindau peptide vaccine

Search for papers about von Hippel-Lindau peptide vaccine

Search papers
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)